Mark Page
Impact in
- Virology top 1%
- HIV Research and Treatment
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- HIV/AIDS drug development and treatment
Papers in
-
- Protein purification and stability 24
- Glycosylation and Glycoproteins Research 15
-
- Monoclonal and Polyclonal Antibodies Research 31
- Co-authors
- Robin Thorpe (34 shared papers)Neil Almond (25 shared papers)Andrew F. Rowley (3 shared papers)Giada Mattiuzzo (15 shared papers)Martin Cranage (9 shared papers)P. Kitchin (4 shared papers)F. Taffs (4 shared papers)E. J. Stott (5 shared papers)
- Journals
- Vaccine (8 papers)Retrovirology (6 papers)PLoS ONE (5 papers)Vox Sanguinis (3 papers)AIDS (3 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Mark Page
91 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 114
- Virology 520
- Infectious Diseases 432
- Immunology 401
- Epidemiology 384
- Hepatology 66
Countries citing papers authored by Mark Page
This map shows the geographic impact of Mark Page's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Page with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Page more than expected).
Fields of papers citing papers by Mark Page
This network shows the impact of papers produced by Mark Page. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Page. The network helps show where Mark Page may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Page, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 98 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1990 | 149 | |
| 2 | 1993 | 130 | |
| 3 | 2021 | 86 | |
| 4 | 1989 | 72 | |
| 5 | 2002 | 56 | |
| 6 | 1994 | 50 | |
| 7 | 2006 | 44 | |
| 8 | 2010 | 36 | |
| 9 | 2012 | 33 | |
| 10 | 1990 | 29 | |
| 11 | 2008 | 29 | |
| 12 | 1999 | 27 | |
| 13 | 1983 | 26 | |
| 14 | 2008 | 24 | |
| 15 | 2009 | 24 | |
| 16 | 1995 | 23 | |
| 17 | 1990 | 21 | |
| 18 | 2009 | 20 | |
| 19 | 2011 | 20 | |
| 20 | 2013 | 19 |
About Mark Page
Mark Page is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Virology, Infectious Diseases and Epidemiology, having authored 98 papers that have together received 1.4k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (31 papers), HIV Research and Treatment (26 papers), Protein purification and stability (24 papers), Glycosylation and Glycoproteins Research (15 papers), Viral Infections and Outbreaks Research (12 papers), Hepatitis B Virus Studies (11 papers), Virology and Viral Diseases (10 papers) and Immunotherapy and Immune Responses (9 papers). The work is most often cited by research in Virology (520 citations), Infectious Diseases (432 citations), Immunology (401 citations), Epidemiology (384 citations) and Hepatology (66 citations). Mark Page has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Robin Thorpe, Neil Almond, Andrew F. Rowley, Giada Mattiuzzo, Martin Cranage, P. Kitchin, F. Taffs, E. J. Stott, Philip D. Minor and Woon Ling Chan. Their work appears in journals such as Vaccine, Retrovirology, PLoS ONE, Vox Sanguinis and AIDS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.